APA

Hallek M., Schmitt B., Wilhelm M., Busch R., Kröber A., Fostitsch H. P., Sezer O., Herold M., Knauf W., Wendtner C. M., Kuse R., Freund M., Franke A., Schriever F., Nerl C., Döhner H., Thiel E., Hiddemann W., Brittinger G. & Emmerich B. (20010927). Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. : British journal of haematology.

Chicago

Hallek M, Schmitt B, Wilhelm M, Busch R, Kröber A, Fostitsch H P, Sezer O, Herold M, Knauf W, Wendtner C M, Kuse R, Freund M, Franke A, Schriever F, Nerl C, Döhner H, Thiel E, Hiddemann W, Brittinger G and Emmerich B. 20010927. Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. : British journal of haematology.

Harvard

Hallek M., Schmitt B., Wilhelm M., Busch R., Kröber A., Fostitsch H. P., Sezer O., Herold M., Knauf W., Wendtner C. M., Kuse R., Freund M., Franke A., Schriever F., Nerl C., Döhner H., Thiel E., Hiddemann W., Brittinger G. and Emmerich B. (20010927). Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. : British journal of haematology.

MLA

Hallek M, Schmitt B, Wilhelm M, Busch R, Kröber A, Fostitsch H P, Sezer O, Herold M, Knauf W, Wendtner C M, Kuse R, Freund M, Franke A, Schriever F, Nerl C, Döhner H, Thiel E, Hiddemann W, Brittinger G and Emmerich B. Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group. : British journal of haematology. 20010927.